Symptoms and Progression in FTD-ALS
At a Glance
FTD-ALS commonly causes changes in motivation, language, movement, swallowing, and breathing. Symptoms often progress faster than isolated FTD or ALS, but timing varies; regular monitoring helps the care team adjust support and respond to warning signs.
When frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) occur together, the symptoms are not just a simple addition of two diseases. Instead, they create a unique pattern of change that affects how a person moves, speaks, and processes information [1][2]. Understanding this progression is key to anticipating the care your loved one will need.
The Shift in Personality and Behavior
While people with “pure” FTD often show impulsive or socially inappropriate behavior (disinhibition), those with the combined FTD-ALS diagnosis are more likely to experience a profound loss of initiative, known as apathy [3][4].
Apathy in FTD-ALS often presents as:
- Loss of “Get Up and Go”: The person may sit for hours without starting an activity or conversation, even if they are physically able to do so [4].
- Reduced Emotional Warmth: They may seem less responsive to family news or emotional events, which is a result of the disease affecting the brain’s emotional processing centers [3].
- Executive Dysfunction: Difficulty with complex tasks, like planning a meal or managing finances, often appears early [3].
Language and Communication Challenges
Language impairment is extremely common in FTD-ALS. In some study cohorts, nearly 90% of patients showed language impairments [1]. This is often more than just “forgetting words.” It is important to distinguish between aphasia (a language processing issue in the brain) and dysarthria (impaired speech motor control due to muscle weakness).
- Syntactic Comprehension (Aphasia): One of the most distinct signs is difficulty understanding the “logic” of a sentence [5]. For example, a patient might struggle to understand “The boy was chased by the dog,” even if they know what “boy,” “dog,” and “chase” mean [5].
- Anomia (Aphasia): This is the classic “tip of the tongue” feeling where a person cannot find the name for common objects [1].
- Agrammatism (Aphasia): Speech may become “telegraphic,” leaving out small words like “the,” “and,” or “is” [2].
Motor Symptoms: The Physical Connection
Because ALS affects the motor neurons (the nerves that control muscles), physical changes will eventually emerge. If your loved one started with FTD symptoms, motor signs may appear later; one study found a median interval of 12 to 24 months, though this interval varies substantially from person to person [6].
- Upper Motor Neuron (UMN) Signs: These occur when the brain cannot send clear signals to the spinal cord. Signs include spasticity (muscle stiffness), unusually brisk reflexes, and a general “clumsiness” [7][8].
- Lower Motor Neuron (LMN) Signs: These occur when the nerves connecting the spinal cord to the muscles fail. You may see muscle atrophy (wasting away), weakness, and fasciculations—small, involuntary muscle twitches that look like “rippling” under the skin [8].
Bulbar Symptoms: Speech and Swallowing
The “bulbar” region refers to the muscles controlled by the brainstem, which are used for speaking, swallowing, and managing saliva.
- Dysarthria: Speech may become slow, slurred, or “labored,” often described as sounding like the person has a “thick tongue” [9].
- Dysphagia: Difficulty swallowing can lead to coughing or choking during meals [7].
- Sialorrhea: This is the medical term for excessive drooling or difficulty managing saliva, which happens when swallowing becomes less frequent or efficient [10].
Tracking the Progression
The progression of FTD-ALS is generally faster than either “pure” FTD or “pure” ALS [11]. On average, when the disease begins with motor symptoms, the progression may be quicker than when it begins with cognitive changes, though every person’s journey is different [12].
Doctors often use the ECAS (Edinburgh Cognitive and Behavioural ALS Screen) to track these changes. The frequency of testing should be individualized based on symptoms, communication ability, and clinic practice [13]. Because the physical symptoms of ALS can make traditional memory tests difficult (for example, if a patient cannot write or speak clearly), the ECAS is specifically designed to be “communication-sensitive,” ensuring that the doctor is measuring the patient’s thinking, not just their physical ability to respond [14][15]. Monitoring these changes helps your care team adjust support strategies before a crisis occurs [11].
Urgent Warning Signs Checklist:
- Call 911 / Emergency Services Now: Inability to breathe, speak, or cough; cyanosis (turning blue/gray); sudden severe breathlessness; a severe choking episode with ongoing respiratory symptoms.
- Call the Care Team Soon (Same-Day): New wet voice, gradual prolonged meals, increasing coughing during meals, or new swallowing changes.
Common questions in this guide
Why might someone with FTD-ALS seem apathetic or lose interest in activities?
How can we tell a language problem from weak or slurred speech in FTD-ALS?
What movement changes can happen as FTD-ALS progresses?
Which swallowing or breathing changes need urgent medical attention?
How fast does FTD-ALS progress, and how is it monitored?
What should families track as FTD-ALS symptoms change?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which motor signs are currently present (upper vs. lower motor neuron), and how does that help confirm the diagnosis?
- 2.Is the language difficulty we are seeing more like 'word-finding' (anomia) or 'grammar-building' (syntactic comprehension), and how will we track this over time?
- 3.What is the plan for managing bulbar symptoms like saliva control or swallowing changes as they emerge?
- 4.Based on the current symptoms, should we be using the ECAS or a similar tool to monitor cognitive and language changes?
- 5.Does my loved one show signs of apathy specifically, and how can we differentiate this from depression in our care plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.
Long Z, Irish M, Piguet O, et al.
Journal of neurology 2019; (266(4)):921-933 doi:10.1007/s00415-019-09216-0.
PMID: 30707358 - 2
Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
Vinceti G, Olney N, Mandelli ML, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(3-4)):146-158 doi:10.1080/21678421.2018.1556695.
PMID: 30668155 - 3
Examining the language and behavioural profile in FTD and ALS-FTD.
Saxon JA, Thompson JC, Jones M, et al.
Journal of neurology, neurosurgery, and psychiatry 2017; (88(8)):675-680 doi:10.1136/jnnp-2017-315667.
PMID: 28596248 - 4
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
Saxon JA, Thompson JC, Harris JM, et al.
Journal of neurology, neurosurgery, and psychiatry 2020; (91(12)):1304-1311 doi:10.1136/jnnp-2020-323969.
PMID: 33055142 - 5
Syntactic comprehension deficits across the FTD-ALS continuum.
Kamminga J, Leslie FVC, Hsieh S, et al.
Neurobiology of aging 2016; (41()):11-18 doi:10.1016/j.neurobiolaging.2016.02.002.
PMID: 27103514 - 6
Heterogeneity of behavioural and language deficits in FTD-MND.
Long Z, Irish M, Foxe D, et al.
Journal of neurology 2021; (268(8)):2876-2889 doi:10.1007/s00415-021-10451-7.
PMID: 33609157 - 7
Primary progressive aphasia and motor neuron disease: A review.
Aiello EN, Feroldi S, De Luca G, et al.
Frontiers in aging neuroscience 2022; (14()):1003792 doi:10.3389/fnagi.2022.1003792.
PMID: 36158556 - 8
Amyotrophic lateral sclerosis; clinical features, differential diagnosis and pathology.
Van Es MA
International review of neurobiology 2024; (176()):1-47 doi:10.1016/bs.irn.2024.04.011.
PMID: 38802173 - 9
Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis.
Aiello EN, Curti B, Torre S, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(2)):775-782 doi:10.1007/s10072-024-07789-x.
PMID: 39404920 - 10
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.
Crockford C, Newton J, Lonergan K, et al.
Neurology 2018; (91(15)):e1370-e1380 doi:10.1212/WNL.0000000000006317.
PMID: 30209236 - 11
Distinct disease trajectories in frontotemporal dementia-motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study.
Long Z, Irish M, Hodges JR, et al.
European journal of neurology 2022; (29(11)):3158-3169 doi:10.1111/ene.15518.
PMID: 35921225 - 12
Phenotypic variability in ALS-FTD and effect on survival.
Ahmed RM, Devenney EM, Strikwerda-Brown C, et al.
Neurology 2020; (94(19)):e2005-e2013 doi:10.1212/WNL.0000000000009398.
PMID: 32277059 - 13
Temporal course of cognitive and behavioural changes in motor neuron diseases.
McHutchison CA, Wuu J, McMillan CT, et al.
Journal of neurology, neurosurgery, and psychiatry 2024; (95(4)):316-324 doi:10.1136/jnnp-2023-331697.
PMID: 37827570 - 14
What is the extent of reliability and validity evidence for screening tools for cognitive and behavioral change in people with ALS? A systematic review.
Didcote L, Vitoratou S, Al-Chalabi A, Goldstein LH
Amyotrophic lateral sclerosis & frontotemporal degeneration 2024; (25(5-6)):437-451 doi:10.1080/21678421.2024.2314063.
PMID: 38415696 - 15
A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen.
Keller J, Krimly A, Bauer L, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(5-6)):443-450 doi:10.1080/21678421.2017.1313869.
PMID: 28420245
This page explains common FTD-ALS symptoms and progression patterns for educational purposes only and does not replace medical advice. Contact your neurologist or care team for individualized guidance, especially when breathing or swallowing changes occur.
Get notified when new evidence is published on Frontotemporal dementia with motor neuron disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.